Alemtuzumab as Treatment for Residual Disease after Chemotherapy in Patients with Chronic Lymphocytic Leukemia

Susan M. O'Brien, Hagop M. Kantarjian, Deborah A. Thomas, Jorge Cortes, Francis J. Giles, William G. Wierda, Charles A. Koller, Alessandra Ferrajoli, Mary Browning, Susan Lerner, Maher Albitar, Michael J. Keating

Research output: Contribution to journalArticlepeer-review

202 Scopus citations

Fingerprint

Dive into the research topics of 'Alemtuzumab as Treatment for Residual Disease after Chemotherapy in Patients with Chronic Lymphocytic Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences